Literature DB >> 20101352

Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study.

A St-Pierre1, B Cantin, B Lamarche, D Auger, Jean- Pierre Després, G R Dagenais.   

Abstract

BACKGROUND: The natural history of intermittent claudication, from its risk factors to its cardiovascular prognosis, has been reported in few prospective studies.
OBJECTIVE: To assess incident intermittent claudication, as well as its risk factors and long-term prognosis in men.
METHODS: A random sample of 4376 men 35 to 64 years of age from Quebec City (Quebec), who were free of cardiovascular disease (CVD), was evaluated in 1974 for CVD risk factors and followed until 1998. To assess the prognosis, the event rates between 1985 and 1998 were computed among men with incident claudication without other CVD, incident survivors of a first myocardial infarction (MI) without other CVD and men free of CVD between 1974 and 1985.
RESULTS: From 1974 to 1998, 300 men developed intermittent claudication. Tobacco consumption, high systolic blood pressure and diabetes at least doubled the adjusted RR (aRR) of intermittent claudication. In 1985, there were 80 claudicants, 2868 men free of CVD and 68 survivors of a first MI. During the 13-year follow-up, a new CVD occurred in 48.8% of the claudicants, in 18.9% of men without CVD (aRR 2.08; 95% CI 1.48 to 2.90) and in 45.6% of MI survivors (aRR compared with claudicants 1.12; 95% CI 0.69 to 1.79). There was also no significant difference between claudicants and MI survivors for fatal CVD, nonfatal CVD and total mortality.
CONCLUSIONS: Men with intermittent claudication are at high risk for CVD that may be equivalent to men with previous MI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101352      PMCID: PMC2827219          DOI: 10.1016/s0828-282x(10)70328-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  22 in total

1.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; G Rose
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Fate in intermittent claudication: outcome and risk factors.

Authors:  R Jelnes; O Gaardsting; K Hougaard Jensen; N Baekgaard; K H Tønnesen; T Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study.

Authors:  G R Dagenais; N M Robitaille; P J Lupien; A Christen; S Gingras; S Moorjani; F Meyer; J Rochon
Journal:  Can J Cardiol       Date:  1990-09       Impact factor: 5.223

4.  Intermittent claudication: factors determining outcome.

Authors:  W G Hughson; J I Mann; D J Tibbs; H F Woods; I Walton
Journal:  Br Med J       Date:  1978-05-27

5.  Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.

Authors:  Helaine E Resnick; Robert S Lindsay; Mary McGrae McDermott; Richard B Devereux; Kristina L Jones; Richard R Fabsitz; Barbara V Howard
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

6.  Intermittent claudication: prevalence and risk factors.

Authors:  W G Hughson; J I Mann; A Garrod
Journal:  Br Med J       Date:  1978-05-27

7.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

8.  Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study.

Authors:  W B Kannel; J C Evans; S Piper; J M Murabito
Journal:  J Clin Epidemiol       Date:  2008-05-20       Impact factor: 6.437

9.  Prevalence of intermittent claudication and its effect on mortality.

Authors:  A Reunanen; H Takkunen; A Aromaa
Journal:  Acta Med Scand       Date:  1982

10.  Update on some epidemiologic features of intermittent claudication: the Framingham Study.

Authors:  W B Kannel; D L McGee
Journal:  J Am Geriatr Soc       Date:  1985-01       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.